IBJNews

Roche acquires assets from Virginia IT company

Back to TopCommentsE-mailPrintBookmark and Share

Roche Diagnostics Corp. has agreed to acquire certain assets of Charlottesville, Va.-based Medical Automation Systems Inc.

Terms of the deal, announced on Wednesday, call for Roche to acquire all the assets associated with the company’ RALS point-of-care information technology connectivity system. Roche also will purchase the names “Medical Automation Systems” and “RALS.”

Roche Diagnostics, a Swiss company that has its U.S. headquarters in Indianapolis, said it expects to retain 100, or most, of MAS’ employees.

“As a global leader in [point-of-care] testing, Roche is committed to helping improve the quality of patient care by providing products that support clinical decision-making,” Roche Diagnostics President and CEI Jack Phillips said in a written statement. “With this acquisition, we will build on our strategy to deliver integrated testing solutions to our customers.”

MAS’ point-of-care information management system is used in more than 2,000 hospitals in the United States.

Roche Diagnostics develops and commercializes technology in the field of serum-based laboratory and point-of-care testing, including its products used to monitor coagulation and blood glucose. They are used with the RALS information management systems in health care facilities across the country.

Roche has more than 80,000 employees worldwide, including roughly 2,900 at its campuses in Indianapolis and Fishers.
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT